Journal profile · Clinical Neurology
Stroke
ISSN 0039-2499 · eISSN 1524-4628 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Monthly · Founded 1970
Stroke: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 10.93; hybrid open access; median 150 days to acceptance (32 articles, last 24 months); community-reported acceptance: about 5%; 1,751 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Stroke is published by Lippincott Williams and Wilkins Ltd. and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Acute Ischemic Stroke Management, Cerebrovascular and Carotid Artery Diseases and Stroke Rehabilitation and Recovery, together about 49.9% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Representing the best clinical and basic investigation of all aspects of cerebral circulation and its diseases for more than 50 years.
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Editor-in-chief Argye E. HillisPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Ischemic Stroke ManagementMedicine25.7%
- Cerebrovascular and Carotid Artery DiseasesMedicine14.9%
- Stroke Rehabilitation and RecoveryMedicine9.3%
- Intracerebral and Subarachnoid Hemorrhage ResearchMedicine6.8%
- Intracranial Aneurysms: Treatment and ComplicationsMedicine6.2%
- Traumatic Brain Injury and Neurovascular DisturbancesMedicine5.7%
- Neurological Disease Mechanisms and TreatmentsNeuroscience4%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
| Minor | Peripheral Vascular Disease | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
| Minor | Peripheral Vascular Disease | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
| Minor | Peripheral Vascular Disease | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 10.93LetPub ·
- CiteScore 2026-06
- 13.1LetPub ·
- SJR 2026-06
- 2.86LetPub ·
- SNIP 2026-06
- 2.91LetPub ·
- h-index
- 292LetPub ·
- h-index
- 458OpenAlex ·
- i10-index
- 18,879OpenAlex ·
- 2-year mean citedness
- 2.11OpenAlex ·
- Self-citation rate
- 3.6%LetPub ·
- Share of gold OA articles
- 16.12%LetPub ·
Volume
- Articles per year
- 357LetPub ·
Articles by year OpenAlex count · 49,306 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,658 | 115 | 525 |
| 2025 | 1,751 | 218 | 2,807 |
| 2024 | 1,533 | 232 | 7,101 |
| 2023 | 1,437 | 371 | 12,390 |
| 2022 | 1,446 | 462 | 16,617 |
| 2021 | 1,893 | 614 | 29,277 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
150 daysMedian, submission to acceptance · P25–P75 108 days – 211 days
- Acceptance to online
- median 22 days (32 articles)
- Submission to online
- median 175 days
- Sample
- 32 articles with submission and acceptance dates (3,565 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 5%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- case reportCase Report January 26, 2026Free AccessLength not stated
- commentaryCommentary October 27, 2025Free AccessLength not stated
- research articleResearch Article September 17, 2026Length not stated
- review articleReview Article September 17, 2026Length not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1970
- ISSN
- 0039-2499
- Electronic ISSN
- 1524-4628
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Stroke
What CAS zone is Stroke in?
In the 2025 upgraded edition of the CAS Journal Ranking, Stroke is in Zone 1 of Medicine, and in Zone 1 of the minor category Clinical Neurology / Peripheral Vascular Disease; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Stroke?
The latest impact factor listed by LetPub is 10.93; CiteScore 13.1, h-index 458.
How long does peer review take at Stroke?
Based on the dates recorded on 32 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 150 days (interquartile range 108–211 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Stroke?
According to LetPub and DOAJ records, Stroke is indexed in SCIE and Scopus.
Is Stroke open access, and what is the APC?
Stroke is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .